Lv2
190 积分 2024-11-13 加入
Efficacy of bevacizumab in hereditary hemorrhagic telangiectasia: a systematic review and network meta-analysis
4小时前
待确认
Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia
1天前
已完结
A proof-of-mechanism trial in asthma with lunsekimig, a bispecific NANOBODY molecule
7天前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
20天前
已完结
Benralizumab: First Global Approval
23天前
已完结
Biological Therapies in Chronic Obstructive Pulmonary Disease: New Directions in Personalised Respiratory Medicine
23天前
已完结
Tezepelumab: First Approval
23天前
已完结
Benralizumab: First Global Approval
30天前
已完结
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
1个月前
已完结
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
1个月前
已完结
皖公网安备34019202002308
